NIPH Clinical Trials Search

Basic Information

Recruitment status	recruiting
Health condition(s) or Problem(s) studied
Date of first enrollment	26/06/2020
Target sample size	12500
Countries of recruitment	Japan,Asia except Japan,North America,South America,Europe,Oceania
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : tirzepatide Therapeutic category code : 249 Other hormone preparations (including antihormone preparations) Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : dulaglutide Therapeutic category code : 249 Other hormone preparations (including antihormone preparations) Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy
Secondary Outcome	safety efficacy

Key inclusion & exclusion criteria

Age minimum	>= 40age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria